Today
It’s a banker bonanza as Permira eyes its $4b I-MED payday
The firm’s dealmakers have tapped Jefferies to join their sell-side advisory lineup, alongside Morgan Stanley – which has kept close to the company for years.
- Sarah Thompson, Kanika Sood and Emma Rapaport
This Month
Telix shares hit new high on upgraded revenue forecast
The biotech’s shares double in value this year due to strong sales in the United States for its prostate cancer imaging product.
- Michael Smith
Ramsay’s French asset posts weaker earnings, launches debt refinancing
The healthcare provider says lower government subsidies and inflation are hurting the performance of its Ramsay Sante business.
- Michael Smith
- Opinion
- Opinion
Vested interests at play in the chronic disease explosion
A search for good nutrition opened a Pandora’s box of snake oil salesmen and crackpot solutions. It also provided clues to the surging levels of chronic disease.
- Tony Boyd
- Opinion
- Investing
How to invest in the golden age of health disruption
Investing in healthcare in today’s market combines exposure to two key drivers – structural demand growth and disruptive innovation.
- Andrew McAuley
Are you overweight or obese? Depends on where you carry your fat
European experts have developed a new framework to modernise the staging, diagnosis and management of obesity.
- Jill Margo
Forced smiles: Crescent Capital, Genesis get their fangs out
Pacific Smiles has been in a holding pattern since the dispute broke out.
- Sarah Thompson, Kanika Sood and Emma Rapaport
I-MED snaps up US teleradiology player StatRad
Aussie imaging giant I-MED is hoping to recreate its fast-growing teleradiology business in the US with a major acquisition.
- Tess Bennett
- Exclusive
- Venture capital
Frazis unveils venture capital fund, makes first investments
The Gen Y tech investor has nabbed stakes in a dozen start-ups in tech, health and e-commerce, thanks to $10 million raised from wealthy investors.
- Tom Richardson
June
Why people with cancer don’t get the full benefit of clinical trials
Australian researchers say regulators should mandate the requirement to share data.
- Jill Margo
- Exclusive
- Industrial relations
Nurses identify ‘$1.2bn’ in savings for 15 per cent pay rise
Deloitte’s report for the NSW nurses’ union found the state government may have missed out on more than $3 billion in Commonwealth funding due to inaccurate data.
- David Marin-Guzman
Radiology’s AI future and deregulation help end years of bad blood
The No.1 player in an industry sets the tone. And in radiology, the tone is deals, deals, deals.
- Anthony Macdonald
Integral Diagnostics dealmaking creates $1b diagnostics giant
The company has proposed a merger with its smaller rival, Capitol Health, creating the largest pure-play diagnostics imaging group on the ASX.
- Kylar Loussikian
- Opinion
- Hospitals
The bottom line is private hospitals are evolving, not collapsing
The government’s “financial health check” review should kick-start a conversation about innovation and the fate of some old, inefficient facilities.
- Matthew Koce
Telix pulls $300m Nasdaq IPO as investors demand deep discount
The cancer treatment hopeful had announced plans to list in New York only last week as it searched for more capital. On Friday, it withdrew from the initial public offering.
- Kylar Loussikian
- Exclusive
- Mark Butler
Private hospitals open books for urgent ‘health check’
Health Minister Mark Butler has launched an urgent review into the $22 billion private hospital system.
- Tom McIlroy
Inside Chemist Warehouse’s $600m money spinner
It has nothing to do with medicine. Instead, its advertising business – retail media – spans everything from an in-house ad agency to television and radio.
- Carrie LaFrenz and Sam Buckingham-Jones
Cryogenic start-up focuses on thawing the frozen waiting for a cure
A former child prodigy is working on ways to ensure that bodies can be revived when the time is right.
- Ashlee Vance
Sonic Healthcare-backed Harrison.ai boots up $100m-plus Series C raise
Harrison.ai’s management team has commenced discussions with a handful of potential investors regarding the cash call.
- Sarah Thompson, Kanika Sood and Emma Rapaport
TPG hires industry heavy hitters for $1.5b fund; eyes 3.2-times money
Former Telstra chief executive Andy Penn has signed up to lead the $1.5 billion TPG Emerging Companies Asia Fund’s efforts in new economy and cyber sectors.
- Sarah Thompson, Kanika Sood and Emma Rapaport
